Stock listing

NASDAQ:ADGM Adagio Medical Holdings, Inc Stock

Home listing (NASDAQ) of Adagio Medical Holdings, Inc

Follow Adagio Medical Holdings, Inc into a list and get an email when it puts out news.

Share price · NASDAQ:ADGM

$1.75 USD +0.23 (+15.1%)

Close on Nov 20, 2026

Past year +122.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.60 – $1.84 USDNov 20, 2026
Volume
27,722 sharesNov 20, 2026
Market cap
$1.72M USDAt the close on Nov 20, 2026 · price × 983,434 shares outstanding
52-week range
$0.081 – $2.32 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$371,032 USDMedian day 329,392 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Adagio Medical Holdings, Inc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ADGM · Home$1.75 USD+0.23 (+15.1%)27,722$1.60$1.84$1.60$1.52Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ADGM · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.75+0.23+15.1%$1.60$1.84$1.6027,722
$1.52-0.13-7.9%$1.632$1.64$1.529,174
$1.65+0.04+2.5%$1.54$1.65$1.4513,696
$1.61-0.32-16.6%$1.93$2.10$1.4692,103
$1.93+0.11+6.0%$1.82$1.964$1.8236,045
$1.82-0.05-2.7%$1.89$2.25$1.62379,099
$1.87+0.03+1.6%$1.84$1.87$1.6152,494
$1.84-0.08-4.2%$1.60$1.90$1.50187,311
$1.92-0.03-1.5%$2.19$2.32$1.801,103,137
$1.95+0.12+6.6%$1.86$2.04$1.8046,600
$1.83+1.744+2023.0%$2.25$2.25$1.56206,740
$0.0860.000.0%$0.09$0.09$0.085155,850
$0.086-0.001-0.9%$0.089$0.089$0.082155,476
$0.087+0.004+4.8%$0.092$0.093$0.085276,954
$0.083-0.003-3.5%$0.091$0.092$0.081497,322
$0.086-0.02-18.9%$0.108$0.115$0.0831,178,820
$0.106+0.006+6.1%$0.094$0.11$0.09934,444
$0.10+0.003+3.4%$0.098$0.108$0.095299,584
$0.097-0.006-5.8%$0.10$0.108$0.092623,467
$0.103-0.008-7.4%$0.108$0.11$0.101712,624
$0.111-0.005-3.9%$0.112$0.114$0.105181,907
$0.115-0.006-4.6%$0.118$0.122$0.108768,738
$0.121+0.001+0.7%$0.121$0.123$0.115775,851
$0.12+0.021+21.2%$0.101$0.124$0.0963,109,302
$0.099-0.004-3.9%$0.101$0.106$0.095626,074
$0.103+0.014+15.7%$0.088$0.106$0.08425,148,547
$0.089-0.036-29.0%$0.122$0.126$0.0833,211,320
$0.125-0.007-5.1%$0.13$0.136$0.121793,854
$0.132+0.002+1.5%$0.13$0.142$0.1261,271,072
$0.130.000.0%$0.126$0.13$0.126690,432
$0.13-0.004-2.8%$0.13$0.133$0.121,492,363
$0.134-0.004-3.0%$0.135$0.14$0.1251,638,286
$0.138-0.003-2.2%$0.138$0.149$0.131,564,277
$0.141-0.012-7.8%$0.153$0.154$0.1381,632,890
$0.153-0.003-1.9%$0.158$0.16$0.1491,610,879
$0.156+0.003+2.0%$0.156$0.179$0.157,729,847
$0.153+0.009+6.3%$0.147$0.16$0.141,232,996
$0.144-0.027-15.6%$0.177$0.177$0.122,234,675
$0.171-0.024-12.5%$0.197$0.20$0.1621,881,904
$0.195-0.015-7.1%$0.216$0.22$0.1852,088,722
$0.21-0.018-7.9%$0.21$0.217$0.1765,854,442
$0.228-0.257-53.0%$0.333$0.353$0.21236,573,659
$0.486-0.018-3.5%$0.501$0.515$0.44153,830
$0.503+0.021+4.2%$0.52$0.52$0.461128,460
$0.483-0.038-7.2%$0.506$0.517$0.48197,110
$0.52+0.021+4.2%$0.50$0.523$0.4985,290
$0.499+0.037+8.0%$0.488$0.52$0.46185,524
$0.462+0.012+2.6%$0.455$0.50$0.431313,041
$0.451-0.111-19.7%$0.561$0.60$0.451471,529
$0.561-0.019-3.3%$0.56$0.61$0.5627,198
$0.58-0.025-4.1%$0.59$0.62$0.572100,759
$0.605-0.003-0.4%$0.595$0.64$0.5869,240
$0.608+0.044+7.7%$0.579$0.64$0.55180,600
$0.564+0.023+4.3%$0.534$0.59$0.53297,596
$0.541+0.011+2.0%$0.54$0.548$0.52563,784
$0.53+0.018+3.4%$0.525$0.54$0.50233,163
$0.512-0.016-3.0%$0.54$0.54$0.50391,361
$0.528+0.017+3.4%$0.529$0.55$0.485279,804
$0.511-0.009-1.8%$0.515$0.543$0.50230,473
$0.52-0.002-0.3%$0.54$0.55$0.515120,250
$0.522-0.028-5.1%$0.54$0.565$0.511329,392
$0.55-0.04-6.8%$0.581$0.606$0.55570,644
$0.59-0.059-9.1%$0.64$0.662$0.556436,636
$0.649+0.015+2.4%$0.63$0.68$0.62351,107
$0.634+0.002+0.3%$0.629$0.65$0.623111,154
Ticker
NASDAQ:ADGM
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Adagio Medical Holdings, Inc news

Adagio Medical Holdings, Inc on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
27 in the last 12 months · 48 in all · newest Nov 16, 2026 · oldest 2024
Decks
11 decks · latest Aug 13, 2026

Where Adagio Medical Holdings, Inc is listed

ListingExchangeCountryCurrency
NASDAQ:ADGM · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ADGMBOATSUnited StatesUSD

Valuation

P/E 2.1× against a median of 7.6×: 2nd lowest of 3 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$636,010 USD
P/E
2.1×
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
0.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.1×
Beta vs S&P 500
0.69

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Adagio Medical Holdings, Inc · NASDAQ:ADGMUS$1.72MUS$636,0102.1×n/an/a0.1×n/a0.1×0.69
RemSleep Holdings, Inc. · OTC:RMSLUS$2.09MUS$2.06Mn/a123×n/an/an/an/a-0.01
Fuse Medical, Inc. · OTC:FZMDUS$2.03MUS$4.31M14.8×0.5×7.8×0.3×1.5%0.4×0.54
Nuwellis, Inc. · NASDAQ:NUWEUS$1.84M−US$6.31Mn/a−0.7×n/a0.2×−152.8%0.0×2.26
Vivos Therapeutics, Inc. · NASDAQ:VVOSUS$1.83MUS$2.11Mn/a0.1×n/a0.8×−107.1%0.2×1.41
Autonomix Medical, Inc. · NASDAQ:AMIXUS$1.82M−US$5.87Mn/an/an/a0.3×n/a0.0×1.79
Escalon Medical Corp. · OTC:ESMCUS$1.71M−US$1.96M0.4×−0.1×n/a0.3×32.8%0.0×-0.06
Therma Bright Inc. · TSXV:THRMUS$1.66MUS$1.64Mn/a17.3×n/an/an/an/a-0.15
Nexalin Technology, Inc. · NASDAQ:NXLUS$1.45MUS$1.88Mn/a6.8×n/a5.5×n/a4.7×0.52
Zero Candida Technologies Inc. · TSXV:ZCTUS$1.43M−US$59,297n/an/an/a2.2×n/a0.0×-0.17
Osteopore Ltd. · ASX:OSXUS$1.38MUS$596,079n/a0.3×n/an/a−121.8%n/an/a
Median of the othersUS$1.76MUS$1.12M7.6×0.4×7.8×0.3×−107.1%0.0×0.52

Forecasts

2 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
105.00 USD · Analysts' mean
EPS, year to Dec 2026
-30.30 · 2 analysts

Team and board

Officers

OfficerRole
Ilya GrigorovVice President
Deborah KasterChief Business Officer

Board

DirectorRole
Sean SalmonDirector

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026 · Before open−16.6%
Q2 2026Aug 11, 2026 · Before open−3.4%
Q1 2026May 12, 2026 · Before open−1.8%
Q4 2025Mar 27, 2026 · Before open−1.6%
Q3 2025Nov 12, 2025−6.5%
Q2 2025Aug 14, 2025+0.8%
Q1 2025May 15, 2025−3.3%
Q4 2024Mar 27, 2025+0.5%
Q1 2023Apr 6, 2023−0.1%
Q3 2022Nov 7, 20220.0%
All 16 quarters
QuarterResultsShare move
Q2 2022Aug 8, 2022−0.2%
Q1 2022May 13, 2022−0.4%
Q4 2021Mar 31, 2022−0.4%
Quarter to Sep 30, 2021Nov 12, 20210.0%
Quarter to Jun 30, 2021Aug 12, 2021+0.2%
Quarter to Mar 31, 2021May 13, 2021−3.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck24 slidesAug 13, 2026
BofA Securities 2026 Health Care ConferenceConference25 slidesMay 2026
Technical Presentation (April 2026)Technical20 slidesApr 27, 2026
Investor Presentation (February 2026)Investor deck25 slidesFebruary 2026
Technical Presentation (October 2025)Technical15 slidesOct 10, 2025
Investor Presentation (August 2025)Investor deck20 slidesAugust 2025
B of A Securities Health Care Conference 2025Conference16 slidesMay 13, 2025
TD Cowen 45th Annual Healthcare Conference 2025Conference24 slidesMar 4, 2025
SPAC Merger (June 2024)SPAC merger94 slidesJun 11, 2024
SPAC Merger (April 2024)SPAC merger95 slidesApr 24, 2024
All 11 decks
DeckKindSlidesDate
SPAC Merger (February 2024)SPAC merger77 slidesFeb 14, 2024

Open Decks

Financings

RaiseDate
Private placement of shares of common stock (or pre-funded warrants) and accompanying common warrants
Announced: about US$19M · US$1.9403 a share · Warrants at US$1.71 for 60 months · Piper Sandler +1
Dealers: Piper Sandler (lead), Lake Street
Buyers: Perceptive Advisors, LLC (affiliate)
Use of proceeds: Working capital and general corporate purposes, including clinical and product development activities
Oct 15, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue0269.0K300.0K189.0K270.0K
Cost of revenue684.0K1.94M1.31M875.0K1.16M
Gross profit-684.0K-1.67M-1.01M-686.0K-888.0K
Research and development10.6M4.63M15.4M17.9M15.4M
Selling, general and administrative10.6M11.5M1.01M6.61M
Operating income-21.9M-62.5M-27.9M-23.9M-20.6M-13.5K
Depreciation and amortization970.0K1.39M532.0K495.0K336.0K
EBITDA-20.9M-61.1M-27.4M-23.4M-20.3M
Interest expense2.91M1.10M1.66M137.0K0
Income before tax-25.3M-53.8M-36.6M-23.7M-19.9M-13.5K
Income tax000
Net income-25.1M-53.8M-36.6M-23.7M-19.9M-13.5K
Earnings per share, basic-1.51-3.54-48.16-37.02-1.04-0.00
Earnings per share, diluted-1.51-48.16

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents17.1M20.6M1.38M5.55M18.9M
Short-term investments1.36M
Receivables035.0K71.0K-6.59M33.0K
Inventory1.67M2.57M3.32M367.0K334.0K
Current assets20.1M25.3M5.18M6.73M19.7M1.75K
Property, plant and equipment1.53M1.96M1.49M
Goodwill14.0M14.0M0
Total assets43.3M48.4M6.83M8.70M21.4M42.5K
Accounts payable1.08M2.84M3.83M1.01M578.0K25.0K
Current liabilities8.23M7.76M47.2M13.0M2.59M56.0K
Long-term debt21.0M16.1M143.0K
Total debt21.0M17.2M38.3M9.80M11.2K
Total liabilities30.9M28.5M47.4M104.6M94.1M56.0K
Shareholders' equity12.4M19.9M-132.0M-95.9M-72.6M-13.5K
Shares outstanding740.3K15.2M779.9K639.5K19.2M19.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-19.0M-29.5M-25.7M-22.4M-19.3M
Capital spending-374.0K-1.65M-333.0K-492.0K-1.27M
Free cash flow-19.4M-31.1M-26.0M-22.9M-20.6M
Cash from investing-374.0K-1.65M-340.0K-500.0K-1.27M
Cash from financing16.1M15.6M21.9M9.53M130.0K
Share buybacks-115.1M
Change in cash-3.48M20.6M-4.16M5.05M-20.4M

Open Financials

Filings

FilingDateTypeFiled with
DEF 14A · Proxy statementNov 20, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
8-K · Current reportNov 16, 2026ResultsSEC
PRE 14A · Preliminary proxy statementNov 10, 2026Meeting noticeSEC
8-K · Current reportNov 5, 2026Current reportSEC
8-K · Current reportOct 26, 2026Meeting outcomeSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
DEF 14A · Proxy statementOct 13, 2026Meeting noticeSEC
8-K · Current reportOct 1, 2026FinancingSEC
Show 200 filings
FilingDateTypeFiled with
PRE 14A · Preliminary proxy statementOct 1, 2026Meeting noticeSEC
8-K · Current reportSep 23, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
8-K · Current reportAug 14, 2026Current reportSEC
8-K · Current reportAug 13, 2026Current reportSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
8-K · Current reportAug 11, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 28, 2026Big-stake noticeSEC
10-K/A · Annual report, amendedJul 13, 2026Annual reportSEC
8-K · Current reportJun 16, 2026Meeting outcomeSEC
8-K · Current reportJun 12, 2026Current reportSEC
8-K · Current reportMay 21, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 13, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 12, 2026Quarterly reportSEC
8-K · Current reportMay 12, 2026ResultsSEC
ARS · Annual report to shareholdersApr 30, 2026Annual reportSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
8-K · Current reportApr 27, 2026Current reportSEC
8-K · Current reportApr 20, 2026Current reportSEC
8-K · Current reportApr 8, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveApr 6, 2026Other filingsSEC
EFFECT · Notice that a registration is effectiveApr 6, 2026Other filingsSEC
S-8 POSApr 2, 2026Offer documentSEC
POS AM · Amendment to an effective registrationApr 2, 2026Offer documentSEC
POS AM · Amendment to an effective registrationApr 2, 2026Offer documentSEC
POS AM · Amendment to an effective registrationMar 31, 2026Offer documentSEC
POS AM · Amendment to an effective registrationMar 31, 2026Offer documentSEC
S-8 · Registration statement for employee plansMar 27, 2026Offer documentSEC
424B3 · ProspectusMar 27, 2026Offer documentSEC
424B3 · ProspectusMar 27, 2026Offer documentSEC
10-K · Annual reportMar 27, 2026Annual reportSEC
8-K · Current reportMar 27, 2026ResultsSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
4 · Change in ownershipMar 9, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 11, 2026Big-stake noticeSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
424B3 · ProspectusDec 16, 2025Offer documentSEC
424B3 · ProspectusDec 16, 2025Offer documentSEC
8-K · Current reportDec 16, 2025Meeting outcomeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveDec 15, 2025Other filingsSEC
424B3 · ProspectusDec 12, 2025Offer documentSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
3 · Initial statement of ownershipDec 11, 2025Insider tradeSEC
424B3 · ProspectusDec 11, 2025Offer documentSEC
424B3 · ProspectusDec 11, 2025Offer documentSEC
DEFA14A · Additional proxy materialDec 11, 2025Meeting noticeSEC
8-K · Current reportDec 11, 2025Management or board changeSEC
CORRESP · Letter to the SECDec 10, 2025Other filingsSEC
S-3 · Registration statementNov 21, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2025Big-stake noticeSEC
424B3 · ProspectusNov 12, 2025Offer documentSEC
424B3 · ProspectusNov 12, 2025Offer documentSEC
10-Q · Quarterly reportNov 12, 2025Quarterly reportSEC
8-K · Current reportNov 12, 2025ResultsSEC
ARS · Annual report to shareholdersNov 4, 2025Annual reportSEC
DEF 14A · Proxy statementNov 4, 2025Meeting noticeSEC
DOct 29, 2025Other filingsSEC
424B3 · ProspectusOct 24, 2025Offer documentSEC
424B3 · ProspectusOct 24, 2025Offer documentSEC
8-K · Current reportOct 24, 2025Current reportSEC
4 · Change in ownershipOct 22, 2025Insider tradeSEC
424B3 · ProspectusOct 20, 2025Offer documentSEC
424B3 · ProspectusOct 20, 2025Offer documentSEC
8-K · Current reportOct 20, 2025Current reportSEC
424B3 · ProspectusOct 15, 2025Offer documentSEC
424B3 · ProspectusOct 15, 2025Offer documentSEC
8-K · Current reportOct 15, 2025Material contractSEC
424B3 · ProspectusOct 10, 2025Offer documentSEC
424B3 · ProspectusOct 10, 2025Offer documentSEC
8-K · Current reportOct 10, 2025Current reportSEC
424B3 · ProspectusOct 1, 2025Offer documentSEC
424B3 · ProspectusOct 1, 2025Offer documentSEC
8-K · Current reportOct 1, 2025Current reportSEC
3 · Initial statement of ownershipSep 30, 2025Insider tradeSEC
424B3 · ProspectusSep 8, 2025Offer documentSEC
424B3 · ProspectusSep 8, 2025Offer documentSEC
8-K · Current reportSep 8, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 26, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
424B3 · ProspectusAug 13, 2025Offer documentSEC
424B3 · ProspectusAug 13, 2025Offer documentSEC
10-Q · Quarterly reportAug 13, 2025Quarterly reportSEC
8-K · Current reportAug 13, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeAug 12, 2025Big-stake noticeSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
424B3 · ProspectusMay 15, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 15, 2025Quarterly reportSEC
8-K · Current reportMay 15, 2025ResultsSEC
424B3 · ProspectusMay 1, 2025Offer documentSEC
424B3 · ProspectusMay 1, 2025Offer documentSEC
10-K/A · Annual report, amendedApr 30, 2025Annual reportSEC
3 · Initial statement of ownershipApr 28, 2025Insider tradeSEC
424B3 · ProspectusApr 23, 2025Offer documentSEC
424B3 · ProspectusApr 23, 2025Offer documentSEC
8-K · Current reportApr 23, 2025Management or board changeSEC
8-K · Current reportApr 2, 2025ResultsSEC
S-8 · Registration statement for employee plansMar 27, 2025Offer documentSEC
424B3 · ProspectusMar 27, 2025Offer documentSEC
424B3 · ProspectusMar 27, 2025Offer documentSEC
10-K · Annual reportMar 27, 2025Annual reportSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
424B3 · ProspectusMar 17, 2025Offer documentSEC
424B3 · ProspectusMar 17, 2025Offer documentSEC
8-K · Current reportMar 17, 2025Management or board changeSEC
424B3 · ProspectusMar 4, 2025Offer documentSEC
424B3 · ProspectusMar 4, 2025Offer documentSEC
8-K · Current reportMar 4, 2025Management or board changeSEC
424B3 · ProspectusFeb 28, 2025Offer documentSEC
424B3 · ProspectusFeb 28, 2025Offer documentSEC
8-K · Current reportFeb 28, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 13, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveFeb 10, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveFeb 10, 2025Other filingsSEC
424B3 · ProspectusFeb 7, 2025Offer documentSEC
424B3 · ProspectusFeb 7, 2025Offer documentSEC
424B3 · ProspectusFeb 5, 2025Offer documentSEC
424B3 · ProspectusFeb 5, 2025Offer documentSEC
8-K · Current reportFeb 5, 2025Current reportSEC
CORRESP · Letter to the SECFeb 5, 2025Other filingsSEC
CORRESP · Letter to the SECFeb 5, 2025Other filingsSEC
S-1/A · Registration statement, amendedFeb 4, 2025Offer documentSEC
S-1/A · Registration statement, amendedFeb 4, 2025Offer documentSEC
UPLOAD · Letter from the SECJan 22, 2025Other filingsSEC
UPLOAD · Letter from the SECJan 22, 2025Other filingsSEC
S-1 · Registration statementJan 14, 2025Offer documentSEC
S-1 · Registration statementJan 14, 2025Offer documentSEC
424B3 · ProspectusJan 6, 2025Offer documentSEC
424B3 · ProspectusJan 6, 2025Offer documentSEC
8-K · Current reportJan 6, 2025Material contractSEC
424B3 · ProspectusDec 23, 2024Offer documentSEC
424B3 · ProspectusDec 23, 2024Offer documentSEC
8-K · Current reportDec 23, 2024Management or board changeSEC
3 · Initial statement of ownershipDec 20, 2024Insider tradeSEC
424B3 · ProspectusDec 16, 2024Offer documentSEC
424B3 · ProspectusDec 16, 2024Offer documentSEC
8-K · Current reportDec 16, 2024Material contractSEC
424B3 · ProspectusNov 26, 2024Offer documentSEC
424B3 · ProspectusNov 26, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveNov 26, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveNov 26, 2024Other filingsSEC
POS AM · Amendment to an effective registrationNov 25, 2024Offer documentSEC
POS AM · Amendment to an effective registrationNov 22, 2024Offer documentSEC
424B3 · ProspectusNov 14, 2024Offer documentSEC
424B3 · ProspectusNov 14, 2024Offer documentSEC
10-Q · Quarterly reportNov 14, 2024Quarterly reportSEC
8-K · Current reportNov 14, 2024ResultsSEC
SC 13G · Big-stake noticeNov 13, 2024Big-stake noticeSEC
POS AM · Amendment to an effective registrationNov 8, 2024Offer documentSEC
POS AM · Amendment to an effective registrationNov 8, 2024Offer documentSEC
8-K/A · Current report, amendedNov 4, 2024Current reportSEC
8-K · Current reportNov 1, 2024Current reportSEC
S-8 · Registration statement for employee plansOct 8, 2024Offer documentSEC
4 · Change in ownershipOct 1, 2024Insider tradeSEC
EFFECT · Notice that a registration is effectiveSep 20, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveSep 20, 2024Other filingsSEC
424B3 · ProspectusSep 19, 2024Offer documentSEC
424B3 · ProspectusSep 19, 2024Offer documentSEC
UPLOAD · Letter from the SECSep 17, 2024Other filingsSEC
UPLOAD · Letter from the SECSep 17, 2024Other filingsSEC
CORRESP · Letter to the SECSep 17, 2024Other filingsSEC
CORRESP · Letter to the SECSep 17, 2024Other filingsSEC
S-1 · Registration statementSep 13, 2024Offer documentSEC
S-1 · Registration statementSep 13, 2024Offer documentSEC
10-Q · Quarterly reportAug 26, 2024Quarterly reportSEC
8-K · Current reportAug 19, 2024Current reportSEC
8-K/A · Current report, amendedAug 14, 2024Acquisition or disposalSEC
SC 13G · Big-stake noticeAug 12, 2024Big-stake noticeSEC
8-K · Current reportAug 6, 2024Acquisition or disposalSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC

This page holds 200 of 239 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Adagio Medical Holdings, Inc’s releases · as of Nov 11, 2026

Common shares
983,434
Fully diluted
983,434

Fully diluted

LineSharesAs of
Common shares983,434Nov 11, 2026

Share count over time

CountShares
Nov 11, 2026983,434
Nov 9, 2026

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Perceptive Advisors LLC9.88MUS$1.51MSep 30, 2026
Adage Capital Partners Gp, L.L.C.1.26MUS$193KSep 30, 2026
Alyeska Investment Group, L.P.1.16MUS$177KSep 30, 2026
Geode Capital661KUS$101KSep 30, 2026
Vanguard175KUS$26,729Sep 30, 2026
Silverarc Capital Management, LLC170KUS$26,080Sep 30, 2026
Jane Street119KUS$18,166Sep 30, 2026
Affinity Asset Advisors, LLC80,000US$12,240Sep 30, 2026
Citadel76,212US$11,660Sep 30, 2026
Hrt Financial LP53,814US$8,000Sep 30, 2026
All 22 holders
HolderSharesValueAs of
XTX Topco Ltd45,657US$6,986Sep 30, 2026
Susquehanna39,205US$5,998Sep 30, 2026
Northern Trust30,875US$4,724Sep 30, 2026
TD25,000US$3,825Sep 30, 2026
Point72 Asset Management, L.P.20,143US$3,082Sep 30, 2026
Opaleye Management Inc.18,444US$2,822Sep 30, 2026
Bank of America14,215US$2,175Sep 30, 2026
Nuveen9,347US$1,346Sep 30, 2026
Tower Research Capital LLC (TRC)4,267US$653Sep 30, 2026
Robinhood Markets, Inc.469US$71Sep 30, 2026
Strategic Financial Concepts, LLC19US$3Sep 30, 2026
Barclays1Sep 30, 2026

Funds

HolderSharesValueAs of
Vanguard Extended Market Index Fund91,512US$59,629Jun 30, 2026
Fidelity Extended Market Index Fund66,969US$48,486May 31, 2026
Vanguard Total Stock Market Index Fund17,442US$11,365Jun 30, 2026
Fidelity Series Total Market Index Fund10,400US$7,530May 31, 2026
Fidelity Nasdaq Composite Index Fund5,436US$3,936May 31, 2026

Big stakes

StakeStakeSharesDateFiling
Perceptive Advisors LLC55.40%15.3MMar 31, 2026Schedule 13G
Alyeska Investment Group, L.P.9.90%2.1MDec 31, 2025Schedule 13G
Ra Capital Management, L.P.7.20%1.2MJun 30, 2025Schedule 13G
Adage Capital Management, L.P.5.67%1.26MMar 31, 2026Schedule 13G
ADAR1 Capital Management, LLC5.40%1.21MJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Sandra A Gardiner
Other companies: Kronos Bio Inc (Interim CFO · Sep 15, 2023 – Sep 15, 2023 · Past); Nektar Therapeutics (Chief Financial Officer · Apr 17, 2023 – Apr 17, 2023 · Past); Anebulo Pharmaceuticals, Inc. (Acting Chief Financial Officer · Mar 2, 2023 – Mar 2, 2023 · Past); Lucira Health Inc (Director · Feb 4, 2021 – Jun 1, 2022 · Past); Pulse Biosciences, Inc (CFO & EVP Admin. and Finance · Dec 9, 2020 – Dec 14, 2021 · Past)
Director · Since at least Jul 31, 2024
James L. Cox
Other companies: Lucid Diagnostics Inc. (Director · Since at least Oct 13, 2021); PAVmed Inc. (Director · Apr 1, 2021 – Feb 22, 2024 · Past)
Director · Since at least Jul 31, 2024
Timothy Moran
Other companies: Kestra Medical Technologies, Ltd. (Chief Business Officer · Since at least Oct 7, 2025); Motus GI Holdings, Inc. (Director · Nov 11, 2020 – Mar 5, 2024 · Past)
Director · Since at least Jul 31, 2024
Daniel George
Other companies: Anebulo Pharmaceuticals, Inc. (Acting Chief Financial Officer · Since at least Nov 5, 2026)
Interim CFO · Apr 17, 2025 – Apr 17, 2025 · Past
Orly Mishan
Other companies: Cerevel Therapeutics Holdings Inc (Chief Business Officer · Oct 27, 2020 – Jan 25, 2021 · Past)
Director · Since at least Jul 31, 2024
Deborah KasterChief Business Officer · Since at least Mar 31, 2025
Ilya GrigorovVice President · Since at least Mar 31, 2025
Sean SalmonDirector · Since at least Dec 11, 2025
Todd UsenChairperson of the Board · Since at least Dec 16, 2024

Open People

Log in to ask 6ix AI your own questions about Adagio Medical Holdings, Inc.